|
(Health-NewsWire.Net, October 10, 2022 ) According to Precision Business Insights (PBI), the latest report global endometrial cancer diagnostics market size was estimated at USD 21.4 billion in 2021 and is projected to grow at a CAGR of 5.4% during the forecast period 2022-28. The lower abdomen is where the uterus, a female organ commonly known as the womb, is situated. It aids in fetal development up until delivery. The malignant expansion of uterine tissue cell populations is referred to as uterine cancer. Endometrial carcinoma, as well as uterine sarcoma, as well as uterine sarcoma are the two kinds of uterine cancer. Uterine sarcoma originates in the network of tissues, bones, and muscles that support the uterus, whereas endometrial cancer typically affects the lining of the uterus, commonly known as the endometrium.
View Complete Report: https://precisionbusinessinsights.com/market-reports/endometrial-cancer-diagnostics-market/
The Endometrial Cancer Diagnostics Market Growth Factors:
According to research, the glycoproteins CA19.9, YKL-40, CA72.4, and CA15.3 are helpful diagnostic indicators for patients with endometrial cancer and may present a significant opportunity as advanced and improved tumor marker tests for uterine cancer diagnostic testing in the years to come. The market for uterine cancer diagnostic testing is projected to increase as a result of the early discovery of endometrial cancer in women who have irregular and postmenopausal bleeding, one of the early indications of endometrial carcinoma. Women's endometrial cancer spread is linked to BRCA1 and BRCA2 breast cancer mutations. There is a large window of opportunity for the development of tumor marker tests to identify uterine cancer in the global market.
The Endometrial Cancer Diagnostics Market Segmentation
The global Endometrial Cancer Diagnostics Market on the basis of Type of Condition, the market is segregated into Endometrioid Carcinoma, Serous Adenocarcinoma, Adenosquamous Carcinoma, Carcinomasarcoma. On the basis of Type of Test, the market is categorized into Hysteroscopy, Endometrial Biopsy, Dilation and Curettage, Ultrasound, CT Scan, MRI. On the basis of End user, the market is fragmented into Diagnostic Centers, Hospitals, Ambulatory Surgical Centers.
Request Sample Of The Report https://precisionbusinessinsights.com/request-sample?product_id=22224
The Endometrial Cancer Diagnostics Market Trends
• The factors that are anticipated to drive the market expansion in the future include rising female weight, rising postmenopausal therapy, social determinants, changes in lifestyle choices, poor food, and an increase in the incidence of polycystic ovarian syndrome.
• The three main market trends for the market are growth in knowledge of uterine illnesses, the availability of numerous treatment options, as well as early diagnostic options.
Related Reports:
Breast Biopsy Devices Market by Device type (Needles, Forceps, Guns, Others), Procedure type (Core needle biopsy, Vacuum-assisted core biopsy, Fine needle aspiration biopsy, Stereotactic core needle biopsy, Surgical biopsy, Others), Guidance type ( Ultrasound-guided biopsy, Magnetic resonance imaging (MRI) guided biopsy, Mammography guided stereotactic guided biopsy, Others) end user ( Hospitals, Clinics, Ambulatory surgical centres, Laboratories) and Geography
https://precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/
Biopsy Devices Market By Device Type (Core biopsy devices, Needle-based biopsy devices, Vacuum-assisted biopsy devices, Aspiration biopsy needles, Other), By Application (Gastrointestinal biopsy, Lung, Liver, Breast biopsy, Gynaecological, Kidney, Others), By Imaging Technologies (Ultrasound-guided biopsy, Stereotactic guided biopsy, CT scan, MRI guided biopsy, Others), By End User (Hospitals, Clinics, Diagnostic Centres), and Geography
https://precisionbusinessinsights.com/market-reports/global-biopsy-devices-market/
Liquid Biopsy Market: By-Products and Services (Instruments, Reagents, and Services & Software), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes, and Others), By Sample Type (Blood Samples, Urine Samples, and Other Biofluid Samples), By Application (Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, Leukemia, Lung Cancer, Prostate Cancer, and Other Cancers), By Analysis Method (Multigene – parallel Analysis and Single Gene Analysis (PCR Microarrays)), By End-User (Hospitals, Diagnostic Laboratories, and Academic and Research Institutes), and Geography
https://precisionbusinessinsights.com/market-reports/liquid-biopsy-market/
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Precision Business Insights
Satya
+1-866-598-1553
satya@pbigp.com
Source: EmailWire.Com 
|
